In a patient with tachycardia, portal hypertension, and mucosal bleeding, what investigations should be performed?

Immediate Investigation for Tachycardia, Portal Hypertension, and Mucosal Bleeding

You must perform urgent upper gastrointestinal endoscopy within 12 hours to identify and treat variceal bleeding, which is the most likely life-threatening source of bleeding in this clinical scenario. 1

Initial Diagnostic Workup

Immediate Laboratory Tests

Before endoscopy, obtain the following 1:

• Complete blood count (hemoglobin, platelet count for severity assessment)
• Liver function tests (bilirubin, albumin, transaminases, INR)
• Kidney function tests (creatinine, BUN)
• Coagulation profile (PT/INR, fibrinogen)
• Blood type and crossmatch

Imaging Studies

Doppler ultrasound of the liver should be performed to 2:

• Confirm portal hypertension (look for splenomegaly, portosystemic collaterals)
• Assess portal vein patency (rule out portal vein thrombosis)
• Evaluate hepatic artery and vein flow patterns

Transient elastography (liver stiffness measurement) is the best noninvasive test to assess clinically significant portal hypertension 3:

• LSM ≥25 kPa strongly suggests clinically significant portal hypertension (CSPH)
• LSM ≤15 kPa makes CSPH highly unlikely
• This has superior accuracy compared to blood-based tests like APRI or FIB-4

Endoscopic Evaluation - The Critical Investigation

Upper endoscopy is the definitive diagnostic and therapeutic procedure 1, 4, 1. The timing depends on hemodynamic stability:

For Acute Active Bleeding:

• Perform endoscopy within 12 hours after initiating vasoactive drugs 5
• Look specifically for:
  • Esophageal varices (most common source)
  • Gastric varices (GOV1, GOV2, IGV1 types) 4
  • Portal hypertensive gastropathy (snake-skin or mosaic pattern) 4, 6
  • Gastric antral vascular ectasia (watermelon stomach) 4

Risk Stratification:

The endoscopy findings determine subsequent management and help assess rebleeding risk 1.

Additional Investigations Based on Clinical Context

If Endoscopy is Negative or Bleeding Source Unclear:

Consider CT angiography if 7:

• Small bowel bleeding is suspected
• Hemodynamically stable but ongoing bleeding
• Can identify active extravasation requiring angiographic intervention

Assessment of Portal Hypertension Severity:

While not routinely performed, hepatic venous pressure gradient (HVPG) measurement is the gold standard 3, 8:

• HVPG ≥10 mm Hg = clinically significant portal hypertension
• HVPG ≥12 mm Hg = high risk of variceal bleeding
• HVPG ≥16 mm Hg = associated with higher mortality
• HVPG ≥20 mm Hg = predicts failure to control bleeding

However, HVPG requires specialized expertise and is invasive, so it's typically reserved for research settings or when noninvasive tests are inconclusive 8.

Common Pitfalls to Avoid

1. Do not delay endoscopy waiting for complete laboratory normalization in actively bleeding patients 1

2. Do not rely solely on blood-based tests (APRI, FIB-4) for portal hypertension assessment—they have poor sensitivity (54-56%) and specificity (68-73%) 3

3. Tachycardia in this context likely represents hypovolemia from bleeding, not a primary cardiac issue—focus on the GI source 1

4. Screen for portal vein thrombosis with Doppler ultrasound, as this can complicate portal hypertension and alter management 2, 9

Pre-Endoscopy Management

While arranging investigations, immediately initiate 1:

• Vasoactive drugs (terlipressin, octreotide, or somatostatin)
• Prophylactic antibiotics (reduces mortality in variceal bleeding)
• Restrictive transfusion strategy (target hemoglobin <7 g/dL unless active cardiac disease) 6

The combination of urgent endoscopy with appropriate pre-endoscopic pharmacotherapy forms the cornerstone of diagnosis and management in this clinical scenario.